Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.11B |
| 2 |
Amazon
AMZN
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$972M |
| 4 |
NVIDIA
NVDA
|
+$894M |
| 5 |
Intel
INTC
|
+$766M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$565M |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$563M |
| 3 |
Phillips 66
PSX
|
+$507M |
| 4 |
Eli Lilly
LLY
|
+$345M |
| 5 |
Palo Alto Networks
PANW
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.17% |
| 2 | Financials | 9.79% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 7.69% |
| 5 | Communication Services | 6.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Pulmonx
LUNG
$87M
| $1.05M | ﹤0.01% |
112,808
-24,515
| -18% | -$287K |
|
3027
Zentalis Pharmaceuticals
ZNTL
$347M
| $1.05M | ﹤0.01% |
66,317
-153,201
| -70% | -$2.11M |
|
3028
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
| $1.04M | ﹤0.01% |
21,800
-45
| -0.2% | -$2.14K |
|
|
FLNA
3029
Filana Therapeutics
FLNA
$48.1M
| $1.04M | ﹤0.01% |
51,358
-54,232
| -51% | -$1.25M |
|
3030
Regenxbio
RGNX
$659M
| $1.04M | ﹤0.01% |
49,452
-62,552
| -56% | -$1.11M |
|
|
ONTF
3031
DELISTED
ON24
ONTF
| $1.04M | ﹤0.01% |
145,372
+56,032
| +63% | +$407K |
|
3032
Ezcorp Inc
EZPW
$1.91B
| $1.04M | ﹤0.01% |
91,366
-1,883
| -2% | -$18.6K |
|
3033
Ichor Holdings
ICHR
$2.48B
| $1.03M | ﹤0.01% |
26,781
-18,514
| -41% | -$717K |
|
3034
National Beverage
FIZZ
$2.97B
| $1.03M | ﹤0.01% |
21,760
-16,117
| -43% | -$788K |
|
3035
Monro
MNRO
$410M
| $1.03M | ﹤0.01% |
32,720
-23,575
| -42% | -$729K |
|
3036
iShares MSCI EAFE Value ETF
EFV
$29.2B
| $1.03M | ﹤0.01% |
18,936
+18,046
| +2,028% | +$942K |
|
3037
ANI Pharmaceuticals
ANIP
$1.8B
| $1.03M | ﹤0.01% |
14,882
-10,383
| -41% | -$627K |
|
3038
Centrus Energy
LEU
$3.72B
| $1.03M | ﹤0.01% |
24,682
+5,181
| +27% | +$238K |
|
3039
PUT
Western Digital
WDC
$189B
| $1.02M | ﹤0.01% |
19,845
-59,535
| -75% | -$2.61M |
|
3040
Altimmune
ALT
$597M
| $1.02M | ﹤0.01% |
100,355
+27,932
| +39% | +$284K |
|
|
NVMI
3041
Nova
NVMI
$13.2B
| $1.02M | ﹤0.01% |
5,754
-536
| -9% | -$84.6K |
|
|
TGH
3042
DELISTED
Textainer Group Holdings limited
TGH
| $1.02M | ﹤0.01% |
20,367
-110,614
| -84% | -$5.5M |
|
|
PPLI
3043
People Inc
PPLI
$3.45B
| $1.02M | ﹤0.01% |
23,238
-69,818
| -75% | -$3.01M |
|
3044
TriMas Corp
TRS
$1.45B
| $1.01M | ﹤0.01% |
37,878
-27,818
| -42% | -$694K |
|
3045
Repay Holdings
RPAY
$343M
| $1.01M | ﹤0.01% |
91,878
-55,409
| -38% | -$490K |
|
3046
Kelly Services Class A
KELYA
$528M
| $1.01M | ﹤0.01% |
40,327
-35,311
| -47% | -$792K |
|
3047
CALL
Stanley Black & Decker
SWK
$15.5B
| $1.01M | ﹤0.01% |
10,300
-14,700
| -59% | -$1.35M |
|
3048
Coastal Financial
CCB
$673M
| $1.01M | ﹤0.01% |
25,945
-5,759
| -18% | -$228K |
|
3049
Unitil
UTL
$964M
| $1.01M | ﹤0.01% |
19,261
-17,686
| -48% | -$890K |
|
3050
Savers
SVV
$1.65B
| $1.01M | ﹤0.01% |
52,250
+16,282
| +45% | +$304K |
|
Similar funds
Barclays's Q1 2024 Portfolio in Review
As of Q1 2024, Barclays held 5,511 positions worth $288B, up 5.5% from $273B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q1 2024 filing shows 303 new, 1,218 increased, 2,942 reduced and 472 closed positions. Its largest new stake was Flutter Entertainment: 1,101,287 shares worth $217M. The largest sale was Qualcomm, an estimated $565M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q1 2024 buy was Flutter Entertainment: 1,101,287 shares worth $217M.
- Barclays added most to Apple in Q1 2024, an estimated $3.11B increase.
- Barclays's biggest Q1 2024 reduction was Qualcomm, cutting an estimated $565M.
- Barclays fully exited Splunk Inc in Q1 2024, selling an estimated $210M.
- Barclays's ten largest holdings make up 29% of its $288B portfolio in Q1 2024.
- Barclays opened 303 new positions and closed 472 in Q1 2024.
- Barclays's portfolio value rose 5.5% quarter-over-quarter to $288B.
Based on Barclays's 13F filing for Q1 2024, filed 15 May 2024.